Word: kohlberg
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...Isaac T. Kohlberg is a senior associate provost and the chief technology development officer of the Office of Technology Development...
...starting to. After six years in which growth averaged almost 7% annually, most forecasters expect the economy to expand by less than 4% this year and next. Foreign direct investment poured into Turkey this decade as companies ranging from French insurer Axa to U.S. private-equity firm Kohlberg Kravis Roberts snapped up Turkish assets. But that flood has now been reduced to a trickle. The burgeoning middle class is starting to curb its free-spending ways, and the nation's two major export industries - automobiles and textiles - are watching nervously as international sales drop...
...transaction valued at $21.4 billion. (Bell Atlantic said the figure included $11.8 billion of stock that it plans to issue and the assumption of $9.6 million of TCI debt.) That would make the deal second in size only to the $25 billion purchase of RJR Nabisco by buyout barons Kohlberg Kravis Roberts in 1988. The new giant would boast 28 million cable and phone customers across the U.S. and combined revenues of more than $16 billion, making it by far the largest of the seven Baby Bell companies that were spun off from AT&T in 1984. Most important...
...Ezekowitz, who was a professor at the Medical School for 22 years, said. The deal with Merck, which is one of many between Harvard researchers and the pharmaceutical company, will play an important role in helping the University fulfill its public obligations, said Senior Associate Provost Isaac T. Kohlberg, who heads Harvard’s Office of Technology and Development. “Through this relationship, the public and the patients will benefit because it is only through this relationship that drugs are being developed,” he said. “It’s only through this...
...Accelerator Fund, a pool of private funding earmarked for University life-sciences researchers struggling to enter the commercial arena. “Most of our technologies in life sciences are very embryonic in nature. They’re very early stage technologies,” said Issac T. Kohlberg, director of Harvard’s Office of Technology (OTD) Director, which oversees the fund. “In order to find a partner—be it a company or a group of investors—who are interested in undertaking further development, we need to reach a further stage...